Anjing Gong Selected Research

aplysin

5/2021	Retraction Note to: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR‑181 level.
9/2014	Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anjing Gong Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 09/2014
2	Glioma (Gliomas) 05/2021 - 09/2014
1	Hemorrhage 11/2022
1	Intracranial Hypertension 11/2022
1	Craniocerebral Trauma (Head Injury) 11/2022
1	Cicatrix (Scar) 04/2022
1	Fibrosis (Cirrhosis) 04/2022
1	Adenocarcinoma of Lung 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2017

Drug/Important Bio-Agent (IBA)

3	Temozolomide (Temodar)FDA LinkGeneric 05/2021 - 09/2014
2	aplysinIBA 05/2021 - 09/2014
2	MicroRNAs (MicroRNA)IBA 01/2017 - 09/2014
1	tyramine-deoxysorbitolIBA 11/2022
1	CollagenIBA 04/2022
1	Long Noncoding RNAIBA 04/2022
1	Piwi-Interacting RNAIBA 01/2021
1	Pyruvate CarboxylaseIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Circular RNAIBA 01/2021

Therapy/Procedure

1	Decompressive Craniectomy 11/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Therapeutics 01/2017